20 Candida albicans spontaneously colonize the mucosa of the esophagus, oropharynx, and gastrointestinal system in healthy persons. However, it can cause mucosal candidiasis in these areas ...

Over the next 10 years, it will be important to shift the focus of mucosal immunology research to make further advances. Examination of the mucosal immune system as a global organ, rather than as ...

On TikTok, women are changing their diets to resolve candida overgrowth, all with varying strictness and habits, with three nutritionists explaining to Newsweek how to effectively tackle candida ...

Patients with recurrent esophageal candidiasis caused by fluconazole ... In addition, even selected antifungal susceptibility testing for mucosal isolates is costly and not widely available.

Researchers have developed a continuously replicating model of human lip cells from donated tissue, overcoming challenges in ...

As published in the journal Frontiers in Cell and Developmental Biology, scientists confirmed that they reached an important ...

pylori infection in the human stomach and determine whether infection upregulates epithelial ST6Gal-I expression, a glycosyltransferase that is overexpressed in multiple mucosal cancers including ...

Considering taking supplements to treat vaginal candidiasis? Below is a list of common natural remedies used to treat or reduce the symptoms of vaginal candidiasis. Follow the links to read common ...

Between 2000 and 2006 inclusive, data from approximately 1.8 million inpatients were reported to PHIS from 25 pediatric hospitals studied (Figure 1) of which 62,843 (3%) were prescribed at least 1 ...

Our ongoing studies on anti-fungal immunity revolve around identification of protective antibody to novel vaccine targets on Candida albicans and Aspergillus ... period in the studies of various ...

Consider eye exams if ocular symptoms develop or in long-term use. Monitor for candida infection or other nasal mucosal changes. Avoid eyes. Pregnancy. Nursing mothers. Headache, pharyngitis ...

Company reports Q3 2024 XHANCE net revenue of $20.4 million, an increase of 3% compared to Q3 2023 Company reports positive inflection in new prescriptions of XHANCE starting in September Company ...